TY  - JOUR
AU  - Rodríguez, Manuel
AU  - Pascasio, Juan Manuel
AU  - Fraga, Enrique
AU  - Fuentes, Javier
AU  - Prieto, Martín
AU  - Sánchez-Antolín, Gloria
AU  - Calleja, José Luis
AU  - Molina, Esther
AU  - García-Buey, María Luisa
AU  - Blanco, María Ángeles
AU  - Salmerón, Javier
AU  - Bonet, María Lucía
AU  - Pons, José Antonio
AU  - González, José Manuel
AU  - Casado, Miguel Ángel
AU  - Jorquera, Francisco
AU  - TENOSIMP-B Research Group
PY  - 2017
DO  - 10.3748/wjg.v23.i41.7459
UR  - http://hdl.handle.net/10668/11814
T2  - World journal of gastroenterology
AB  - To demonstrate the non-inferiority (15% non-inferiority limit) of monotherapy with tenofovir disoproxil fumarate (TDF) vs the combination of lamivudine (LAM) plus adefovir dipivoxil (ADV) in the maintenance of virologic response in patients with...
LA  - en
KW  - Adherence
KW  - Costs
KW  - Efficacy
KW  - Hepatitis B
KW  - Lamivudine+Adefovir
KW  - Safety
KW  - Tenofovir
KW  - Adenine
KW  - Adult
KW  - Aged
KW  - Alanine Transaminase
KW  - Antiviral Agents
KW  - DNA, Viral
KW  - Drug Resistance, Viral
KW  - Drug Therapy, Combination
KW  - Female
KW  - Hepatitis B Surface Antigens
KW  - Hepatitis B e Antigens
KW  - Hepatitis B virus
KW  - Hepatitis B, Chronic
KW  - Hospital Costs
KW  - Humans
KW  - Lamivudine
KW  - Male
KW  - Middle Aged
KW  - Organophosphonates
KW  - Prospective Studies
KW  - Tenofovir
KW  - Treatment Failure
KW  - Viral Load
TI  - Tenofovir vs lamivudine plus adefovir in chronic hepatitis B: TENOSIMP-B study.
TY  - research article
VL  - 23
ER  -